ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. — Investor Relations & Filings
Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and commercialization of biopharmaceutical products. The company focuses on genetic engineering, cell therapy, and precision medicine. Its core product portfolio includes recombinant human growth hormone (rhGH) marketed under the brand Ansomone, and recombinant human interferon alpha-2b known as Anterferon. Anke Bio also develops diagnostic reagents, including biochemical and molecular diagnostic kits, and provides services in the fields of oncology and reproductive health. The company maintains a strong emphasis on innovation through its dedicated R&D centers, aiming to provide advanced therapeutic solutions for growth disorders, viral infections, and various cancers. Its operations span the entire value chain from basic research to clinical application and market distribution.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度内部控制审计报告 | 2026-03-30 | Chinese | |
| 关于申请综合授信额度的公告 | 2026-03-30 | Chinese | |
| 关于变更注册资本暨修订《公司章程》的公告 | 2026-03-30 | Chinese | |
| 关于公司第2期员工持股计划存续期届满暨终止的公告 | 2026-03-30 | Chinese | |
| 关于参股公司PA3-17注射液新增适应症获得药物临床试验批准通知书的公告 | 2026-03-04 | Chinese | |
| 关于公司产品拟中选国家集采药品接续采购的公告 | 2026-02-11 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 35333862 | 2025年度内部控制审计报告 | 2026-03-30 | Chinese | ||
| 35333860 | 关于申请综合授信额度的公告 | 2026-03-30 | Chinese | ||
| 35333857 | 关于变更注册资本暨修订《公司章程》的公告 | 2026-03-30 | Chinese | ||
| 35333855 | 关于公司第2期员工持股计划存续期届满暨终止的公告 | 2026-03-30 | Chinese | ||
| 35333854 | 关于参股公司PA3-17注射液新增适应症获得药物临床试验批准通知书的公告 | 2026-03-04 | Chinese | ||
| 35333852 | 关于公司产品拟中选国家集采药品接续采购的公告 | 2026-02-11 | Chinese | ||
| 35333848 | 关于全资子公司通过高新技术企业认定的公告 | 2026-01-20 | Chinese | ||
| 35333846 | 关于部分限制性股票回购注销完成的公告 | 2026-01-08 | Chinese | ||
|
2025
7 filings
| |||||
| 35333843 | 关于选举董事长、副董事长、董事会各专门委员会成员及聘任高级管理人员、其他人员的公告 | 2025-12-26 | Chinese | ||
| 35333841 | 关于第九届董事会第一次会议决议的公告 | 2025-12-26 | Chinese | ||
| 35333840 | 2025年第三次临时股东大会决议公告 | 2025-12-18 | Chinese | ||
| 35333836 | 关于完成董事会换届选举的公告 | 2025-12-18 | Chinese | ||
| 35333799 | 关于安徽安科生物工程（集团）股份有限公司2025年第三次临时股东大会之法律意见书 | 2025-12-18 | Chinese | ||
| 35333797 | 关于选举第九届董事会职工代表董事的公告 | 2025-12-18 | Chinese | ||
| 35333786 | 关于参股公司PA3-17注射液新增适应症申报临床试验获得受理的公告 | 2025-12-04 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55035/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55035 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55035 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55035 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55035}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. (id: 55035)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.